Paquetta N Myrick-Hancock

Paquetta N. Myrick-Hancock serves as a Contracting Officer responsible for managing complex acquisitions across industrial construction, pharmaceutical manufacturing, and medical supply distribution. In this role, she ensures compliance with federal procurement regulations while advancing mission-critical objectives through strategic sourcing, competitive bidding, and contract administration. Her portfolio primarily involves firm-fixed-price and cost-reimbursement contracts, often requiring technical evaluation of construction specifications, GMP compliance, and supply chain integrity. She plays a pivotal role in executing the agency’s acquisition strategy by aligning procurement decisions with operational needs and regulatory frameworks. While specific contractor relationships are not currently documented, her contracting patterns suggest engagement with a broad range of vendors, including large-scale industrial builders, pharmaceutical formulators, and medical wholesale distributors. She likely works with both prime contractors and subcontractors to ensure delivery of high-integrity infrastructure and critical medical supplies, maintaining rigorous oversight throughout the contract lifecycle—from solicitation through closeout. Myrick-Hancock’s procurement activity reflects a strong preference for unrestricted, open competition, with 100% of her awards issued under no set-aside classifications. This indicates a focus on full and open competition rather than socioeconomic set-asides such as 8(a), HUBZone, or SDVOSB programs. Her approach prioritizes technical capability and market competitiveness over socioeconomic targeting, though she remains compliant with all applicable small business participation requirements. Her primary NAICS focus areas include 236210 for industrial building construction, 325412 for pharmaceutical preparation manufacturing, and 423450 for medical equipment wholesale distribution. She specializes in procuring facility upgrades, sterile drug production systems, and high-volume medical supply chains, demonstrating deep familiarity with construction standards, FDA-regulated manufacturing environments, and healthcare logistics. Her technical expertise spans both capital infrastructure and regulated product procurement, positioning her as a key player in mission-support acquisitions within these domains.